Brazzaville/Kigali, 11 May 2016 – Ongoing efforts to prevent and control cervical cancer in the African Region have received a significant boost following the announcement of a pioneering partnership between the World Health Organization African Region (WHO AFRO) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The new partnership, “AFRO Comprehensive Cervical...
Read moreWatch what healthcare stakeholders and regulatory experts are saying today about the opportunities & challenges facing biotherapeutic medicines. On more details of this event, click here: http://ifpma.org/events-2/biotherapeutic-medicines-a-winning-formula-for-patients/
Read moreViral hepatitis – a silent, but preventable epidemic Recent breakthroughs in available treatment options and the broader objectives of the health-related Sustainable Development Goals (SGDs) make the WHO target of eliminating viral hepatitis by 2030 feasible. Earlier this week, the WHO issued updated guidelines for the treatment of hepatitis C infection, to “promote the transition...
Read moreIt seems there is always a new story in the media about an emerging health threat. Right now, understandably, there is significant public concern about the spread of the Zika virus.
Read moreBiotherapeutics play an important role in modern medicine and have a profound impact on patients with serious diseases. A biotherapeutic is a medical product manufactured or extracted from biological sources
Read moreBreakthroughs in the treatment of hepatitis C pose questions on how to make innovations more available to a large number of patients. A new report looks at possible innovative funding solutions for low and middle-income countries (LMICs) to scale up treatments for viral hepatitis and support health systems to deliver them. The report reviews over...
Read moreAppropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Background To help ensure drug product quality and safety, national medicines regulatory authorities (NMRAs) in many countries have implemented, or are considering implementing, import testing requirements for pharmaceuticals, biological/biotechnology and vaccine products entering their countries. Historically such testing requirements may have been necessary to prevent the distribution of unsafe or nonconforming drug products.
Read morePharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and...
Read more